melasma. Chloasma
Conditions
Interventions
Intervention 1: Control Group: In this group 15 patients received a placebo orally, along with topical hydroquinone 4% daily for three months.Monthly patients response to treatment and side effects ar
Treatment - Drugs
Control Group: In this group 15 patients received a placebo orally, along with topical hydroquinone 4% daily for three months.Monthly patients response to treatment and side effects are examined
The intervention group: The group of 15 patients with finasteride 5 mg orally on a daily basis with topical hydroquinone 4% treated on a daily basis for tree month . complications and response to trea
Sponsors
Ahwaz Jondishapur University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: patient with melasma and would like to participate in the study exclusion criteria: pregnant and lactating women, patients treated with anti androgenic drugs, oral contraceptive use
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melasma. Timepoint: Baseline, the end of the first month, the end of second month, the end of the third month. Method of measurement: By observing the amount of blur, uniformity and percentage of skin involvement in four areas of the forehead, right cheek, left cheek and chin. | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with treatment. Timepoint: end of treatment. Method of measurement: Interviews with patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrjuyi Ziba
Ahwaz Jondishapoor University of Medical Sciences
Outcome results
None listed